Domov › Rak želodca › Texas › Houston

Klinične študije za Rak želodca v Houston, TX

42 študij za Rak želodca išče udeležence na lokacijah v Houston in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.

Uradno besedilo študije (angleško)

Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →

A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

Vključevanje udeležencevFaza 2

The University of Texas MD Anderson Cancer Center - Texas Medical Center, Houston

Starost 18 in več · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT06760819

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci

UT MD Anderson Cancer Center, Houston

Starost 40–75 · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT05334069

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

Vključevanje udeležencevFaza 2

The University of Texas MD Anderson Cancer Center, Houston

Starost 18 in več · Vsi spoli · Posodobljeno 1. okt. 2026 · NCT06172478

AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2

Vključevanje udeležencevFaza 2

Research Site, Houston

Starost 18 in več · Vsi spoli · Posodobljeno 30. sep. 2026 · NCT06219941

A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)

Vključevanje udeležencevFaza 2/3

University of Texas MD Anderson Cancer Center, Houston

Starost 18 in več · Vsi spoli · Posodobljeno 30. sep. 2026 · NCT07221149

Phase 3 Study of Cadonilimab Combined With Chemotherapy vs Chemotherapy in Combination With or Without Nivolumab for the 1L Treatment of Participants With HER2-negative, Previously Untreated, Unresectable or Metastatic Gastric/GEJ Adenocarcinoma

Vključevanje udeležencevFaza 3

MD Anderson Cancer Center, Houston

Starost 18 in več · Vsi spoli · Posodobljeno 29. sep. 2026 · NCT07700979

Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)

Vključevanje udeležencevFaza 2

Research Site, Houston

Starost 18–130 · Vsi spoli · Posodobljeno 23. sep. 2026 · NCT05489211

A Study of LY4257496 in Participants With Cancer (OMNIRAY)

Vključevanje udeležencevFaza 1

MD Anderson Cancer Center, Houston

Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07114601

A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

Vključevanje udeležencevFaza 1

Baylor College of Medicine, Houston

Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07213791

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

Vključevanje udeležencevFaza 1/2

MD Anderson, Houston

Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT06128551

Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer

Vključevanje udeležencevFaza 1/2

MD Anderson Cancer Center, Houston

Starost 18 in več · Vsi spoli · Posodobljeno 18. sep. 2026 · NCT05267626

A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors

Vključevanje udeležencevFaza 1

The University of Texas MD Anderson Cancer Center, Houston

Starost 18 in več · Vsi spoli · Posodobljeno 18. sep. 2026 · NCT07705334

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

Vključevanje udeležencevFaza 1

Oncology Consultants, Houston

Starost 18 in več · Vsi spoli · Posodobljeno 10. sep. 2026 · NCT06293898

Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2

Vključevanje udeležencevFaza 3

Research Site, Houston

Starost 18 in več · Vsi spoli · Posodobljeno 9. sep. 2026 · NCT07431281

A Phase 1/1b Study of IAM1363 in HER2 Cancers

Vključevanje udeležencevFaza 1

MD Anderson Cancer Center - University of Texas, Houston

Starost 18 in več · Vsi spoli · Posodobljeno 9. sep. 2026 · NCT06253871

Testing the Combination of the Anticancer Drugs Trastuzumab Deruxtecan (DS-8201a) and Azenosertib (ZN-c3) in Patients With Stomach or Other Solid Tumors

Vključevanje udeležencevFaza 1

UT MD Anderson Cancer Center, Houston

Starost 18 in več · Vsi spoli · Posodobljeno 4. sep. 2026 · NCT06364410

A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors

Vključevanje udeležencevFaza 1/2

The University of Texas MD Anderson Cancer Center, Houston

Starost 18 in več · Vsi spoli · Posodobljeno 2. sep. 2026 · NCT07070232

A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors

Vključevanje udeležencevFaza 1/2

Research Site, Houston

Starost 18 in več · Vsi spoli · Posodobljeno 19. avg. 2026 · NCT07115043

A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors

Vključevanje udeležencevFaza 1

MD Anderson Cancer Center, Houston

Starost 18 in več · Vsi spoli · Posodobljeno 13. avg. 2026 · NCT07066657

A Study of MGC026 in Participants With Advanced Solid Tumors

Vključevanje udeležencevFaza 1

The University of Texas MD Anderson Cancer Center, Houston
University of Texas Health Science Center at Houston, Houston

Starost 18 in več · Vsi spoli · Posodobljeno 11. avg. 2026 · NCT06242470

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

Vključevanje udeležencevFaza 1/2

The University of Texas, MD Anderson Cancer Center, Houston

Starost 18 in več · Vsi spoli · Posodobljeno 11. avg. 2026 · NCT05592626

IDOV-Immune for Advanced Solid Tumors

Vključevanje udeležencevFaza 1

MD Anderson Cancer Center, Houston

Starost 18 in več · Vsi spoli · Posodobljeno 5. avg. 2026 · NCT06910657

A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors

Vključevanje udeležencevFaza 1/2

Oncology Consultants, Houston

Starost 18 in več · Vsi spoli · Posodobljeno 29. jul. 2026 · NCT03526835

Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors

Vključevanje udeležencevFaza 1

Investigative Site #129, Houston

Starost 18 in več · Vsi spoli · Posodobljeno 23. jul. 2026 · NCT06974110

A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors

Vključevanje udeležencevFaza 1

The University of Texas MD Anderson Cancer Center Investigational Pharmacy Services, Houston
The University of Texas MD Anderson Cancer Center, Houston

Starost 18 in več · Vsi spoli · Posodobljeno 22. jul. 2026 · NCT05208762